Celivarone
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Dec 1, 2004 (NCT00233441)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetOTHER
Unknown
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCCCc1oc2ccc(C(=O)OC(C)C)cc2c1C(=O)c1ccc(CCCN(CCCC)CCCC)cc1- Mol. weight
- 533.75 g/mol
- Lipinski Ro5
- 2 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3707403 ↗
Also known as
- 2-benzofuranacetic acid, 3-(4-(2-(diethylamino)ethoxy)-3,5- diiodobenzoyl)-, 1-methylpropyl ester
- celivarone
- celivarone
- celivarone
- ssr149744c
- ssr149744c
- ssr149744c
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00993382 | Phase 2 | Sep 1, 2009 | Sanofi |
| NCT00232310 | Phase 2 | Oct 1, 2005 | Sanofi |
| NCT00232297 | Phase 2 | Jun 1, 2005 | Sanofi |
| NCT00233441 | Phase 2/Phase 3 (Phase 3) | Dec 1, 2004 | Sanofi |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sanofi | For profit | 4 | 4 | 2 | 2004 |
1 organizations
Page 1 / 1